# Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer

> **NCT04168346** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Helsinki University Central Hospital** · enrollment: 202 (estimated)

## Conditions studied

- Gastric Cancer
- Anemia
- Surgery
- Iron Deficiency Anemia
- Surgery--Complications

## Interventions

- **DRUG:** Ferric carboxymaltose
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04168346
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2019-11
- **Primary completion:** 2021-11
- **Final completion:** 2026-11
- **Target enrollment:** 202 (ESTIMATED)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04168346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04168346, "Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04168346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*